CYP3A5 and Headache: Demographic factors may also contribute; women and younger adults tend to experience medication-related headaches more frequently due to hormonal and vascular factors [32], while racial differences in CYP3A4 and CYP3A5 metabolism may underlie variable adverse effect profiles [33].